Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bumetanide for seizure control in drug-resistant temporal lobe epilepsy patients awaiting surgery
IRCT201012115368N1Phase 2Completed
- Sponsor
- Cellular and Molecular Research Center of Tehran University of Medical Sciences
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bumetanide in temporal lobe epilepsy (TLE), sponsored by Cellular and Molecular Research Center of Tehran University of Medical Sciences. Started Apr 2011; status: completed.
02
Drugs
bumetanide
03
Conditions
temporal lobe epilepsy (TLE)
Beyond the preview
Go deeper on IRCT201012115368N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201012115368N1.